Sarepta Therapeutics, Inc. 0L35.L
0L35.L
Sarepta Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0K1R.L
Viridian Therapeutics, Inc. 0LB2.L
Supernus Pharmaceuticals, Inc. 0KCS.L
OPKO Health, Inc. 0I8F.L
DENTSPLY SIRONA Inc. 0Y5E.L
Perrigo Company plc 0IV3.L
Geron Corporation
Sarepta Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0HB0.L
Agios Pharmaceuticals, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0K1R.L
Viridian Therapeutics, Inc. 0LB2.L
Supernus Pharmaceuticals, Inc. 0KCS.L
OPKO Health, Inc. 0I8F.L
DENTSPLY SIRONA Inc. 0Y5E.L
Perrigo Company plc 0IV3.L
Geron Corporation
Performance
| Periode | 0L35.L | 0HF9.L | 0HB0.L | 0JBU.L | 0K1R.L | 0LB2.L | 0KCS.L | 0I8F.L | 0Y5E.L | 0IV3.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -61.61 % | 22.13 % | 47.04 % | 80.88 % | 70.97 % | 66.18 % | 2.85 % | -4.49 % | -12.26 % | -11.27 % |
| YTD | -81.40 % | -4.99 % | 30.39 % | 21.98 % | 15.49 % | 46.51 % | -1.98 % | -30.76 % | -16.20 % | -65.29 % |
| 1Y | -82.01 % | -22.86 % | -5.66 % | -9.72 % | -4.63 % | 54.59 % | -1.32 % | -45.31 % | -13.97 % | -69.86 % |
| 3Y | -79.11 % | -15.10 % | 51.55 % | -72.14 % | 12.79 % | 53.39 % | -22.32 % | -57.41 % | -33.97 % | -47.06 % |
| 5Y | -69.72 % | -6.29 % | 27.75 % | -84.66 % | -18.22 % | 143.19 % | -51.96 % | -73.86 % | -33.97 % | -27.17 % |
| 10Y | -69.72 % | -6.29 % | -45.94 % | -84.66 % | -82.39 % | 28.37 % | -51.96 % | -78.96 % | -33.97 % | -37.62 % |
| From the beginning | -69.72 % | -6.29 % | -45.94 % | -84.66 % | -82.39 % | 28.37 % | -51.96 % | -78.96 % | -33.97 % | -37.62 % |